Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications.

"Conflict of interest statement: The authors declare that there are no conflicts of interest."

"Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors."

"This interventional feasibility study using historical controls, investigated the accuracy, feasibility and usefulness of reporting the DBI in the HMR setting (). The study was conducted between October 2014 and November 2015. The protocol for this study was retrospectively registered with the Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12615000539538. All study participants gave written, informed consent. Ethical approval was obtained from the Executive of the Human Research Ethics Committee of the University of Sydney, Australia (2014/648)."